Influence of obesity on the incidence and treatment of genitourinary malignancies (Q37819422)

23 August 2017

1 reference

title

Influence of obesity on the incidence and treatment of genitourinary malignancies (English)

1 reference

23 August 2017

0 references

Suzanne Biehn Stewart

series ordinal

1

1 reference

PubMed ID

21147540

23 August 2017

Stephen J Freedland

series ordinal

2

1 reference

23 August 2017

13 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

29

1 reference

23 August 2017

5

1 reference

23 August 2017

476-486

1 reference

Prevalence of overweight and obesity in the United States, 1999-2004

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

The epidemiology of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

The epidemiology of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Epidemiologic aspects of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index and risk of prostate cancer in U.S. health professionals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Dietary fat intake and risk of prostate cancer: A prospective study of 25,708 Norwegian men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Anthropometry and prostate cancer risk: a prospective study of 22,248 Norwegian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and prostate cancer: making sense out of apparently conflicting data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and prostate cancer: epidemiology and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Prostate cancer and body size at different ages: an Italian multicentre case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity before age 30 years and risk of advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

The association of body mass index and prostate-specific antigen in a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Does Body Mass Index Affect Preoperative Prostate Specific Antigen Velocity or Pathological Outcomes After Radical Prostatectomy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Influence of Age and Endocrine Factors on the Volume of Benign Prostatic Hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

High fat diet increases the weight of rat ventral prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index as a predictor of prostate cancer: development versus detection on biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Effect of BMI on primary treatment of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and survival after radical prostatectomy: A 10-year prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathological outcomes for obese men: an analysis of the Duke Prostate Center database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and capsular incision at the time of open retropubic radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Robotic-assisted laparoscopic prostatectomy in overweight and obese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Does obesity influence the operative course or complications of robot-assisted laparoscopic prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Radical perineal prostatectomy for treatment of localized prostate cancer in obese and nonobese patients: a matched control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix con

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Prostate brachytherapy in obese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Influence of body mass index on biochemical outcome after permanent prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity is not predictive of overall survival following permanent prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and treatment of prostate cancer: what is the right dose of Lupron Depot?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Interpreting Cancer Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Trends in the sensitivity, positive predictive value, false-positive rate, and comparability ratio of hospital discharge diagnosis codes for acute myocardial infarction in four US communities, 1987-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Risk factors for renal cell cancer: the multiethnic cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index, physical activity, and risk of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity, hypertension, and the risk of kidney cancer in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Renal cell cancer and body size at different ages: an Italian multicenter case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body size and renal cell cancer incidence in a large US cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Surgical treatment of renal neoplasia: evolving toward a laparoscopic standard of care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Laparoscopic radical nephrectomy: comparison of clinical Stage T1 and T2 renal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Retroperitoneal and pelvic extraperitoneal laparoscopy: an international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Laparoscopic complications in markedly obese urologic patients (a multi-institutional review)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Comparison of laparoscopic radical renal surgery in morbidly obese and non-obese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Laparoscopic radical nephrectomy in obese patients: outcomes and technical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Differences in complications and outcomes for obese patients undergoing laparoscopic radical, partial or simple nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Retroperitoneoscopic radical nephrectomy in obese patients: outcomes and considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Comparison of open and laparoscopic nephrectomy in obese and nonobese patients: outcomes stratified by body mass index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Evaluation of the impact of body mass index on outcome among renal mass patients treated with hand-assisted laparoscopic radical nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Obesity and morbid obesity are associated with a greater conversion rate to open surgery for standard but not hand assisted laparoscopic radical nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Body mass index, physical activity, and bladder cancer in a large prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Influence of body mass index on operability, morbidity and disease outcome following radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Increased body mass index predicts increased blood loss during radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Impact of body mass index on radical cystectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.12.011

10.1016/J.UROLONC.2009.12.011

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21147540